Cytonics is a biotechnology research and development company based in Jupiter, FL, specializing in diagnostics and therapeutics for osteoarthritis. They have developed innovative products such as the Fibronectin-Aggrecan Complex Test (FACT) for detecting cartilage damage and the autologous therapy APIC based on the naturally-occurring blood protein Alpha-2 Macroglobulin (A2M) to alleviate joint pain. With over 6,000 patients treated to date, Cytonics is a leader in regenerative medicine and aims to rid the world of the pain and suffering caused by osteoarthritis.
Supported by hundreds of physicians nationwide, Cytonics is focused on disrupting the field of osteoarthritis treatment with their biologic therapies. They are actively developing new A2M-based therapies and seeking strategic partners for out-licensing at critical clinical value inflection points. With a mission to improve the quality of life for those affected by osteoarthritis, Cytonics is at the forefront of research and development in the field of regenerative medicine.
Generated from the website